Evidence map›Paper›PMID 38597630›Full record

ArticleEuropean heart journal. Cardiovascular Imaging2024

Ethnicity differences in geometric remodelling and myocardial composition in hypertension unveiled by cardiovascular magnetic resonance.

Georgios Georgiopoulos, Luca Faconti, Aqeel T Mohamed, Stefano Figliozzi, Clint Asher, Louise Keehn, Ryan McNally, Khaled Alfakih, Samuel Vennin, Amedeo Chiribiri and 3 more

Open access · hybridAbstract readComparative Study
In one paragraph

Article in European heart journal. Cardiovascular Imaging, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 3 countries.

Georgios GeorgiopoulosSchool of Biomedical Engineering and Imaging Sciences, King's College London, St Thomas' Hospital, Room ST0404253 4th Floor Lambeth Wing, St Thomas' Hospital Campus, Westminster Bridge Road, London SE1 7EH, UK.
Luca FacontiBritish Heart Foundation Centre, Department of Clinical Pharmacology, King's College London, St Thomas' Hospital, London, UK.
Aqeel T MohamedSchool of Biomedical Engineering and Imaging Sciences, King's College London, St Thomas' Hospital, Room ST0404253 4th Floor Lambeth Wing, St Thomas' Hospital Campus, Westminster Bridge Road, London SE1 7EH, UK.ORCID 0000-0002-1108-1892
Stefano FigliozziCardio Center, Humanitas Research Hospital I.R.C.S.S., Rozzano, Milan, Italy.ORCID 0000-0003-2991-1548
Clint AsherSchool of Biomedical Engineering and Imaging Sciences, King's College London, St Thomas' Hospital, Room ST0404253 4th Floor Lambeth Wing, St Thomas' Hospital Campus, Westminster Bridge Road, London SE1 7EH, UK.
Louise KeehnBritish Heart Foundation Centre, Department of Clinical Pharmacology, King's College London, St Thomas' Hospital, London, UK.ORCID 0000-0002-2486-9056
Ryan McNallyBritish Heart Foundation Centre, Department of Clinical Pharmacology, King's College London, St Thomas' Hospital, London, UK.
Khaled AlfakihDepartment of Cardiology, Lewisham and Greenwich NHS Trust, London, UK.
Samuel VenninBritish Heart Foundation Centre, Department of Clinical Pharmacology, King's College London, St Thomas' Hospital, London, UK.
Amedeo ChiribiriSchool of Biomedical Engineering and Imaging Sciences, King's College London, St Thomas' Hospital, Room ST0404253 4th Floor Lambeth Wing, St Thomas' Hospital Campus, Westminster Bridge Road, London SE1 7EH, UK.ORCID 0000-0003-3394-4289
Pablo LamataSchool of Biomedical Engineering and Imaging Sciences, King's College London, St Thomas' Hospital, Room ST0404253 4th Floor Lambeth Wing, St Thomas' Hospital Campus, Westminster Bridge Road, London SE1 7EH, UK.ORCID 0000-0002-3097-4928
Philip ChowienczykBritish Heart Foundation Centre, Department of Clinical Pharmacology, King's College London, St Thomas' Hospital, London, UK.
Pier-Giorgio MasciSchool of Biomedical Engineering and Imaging Sciences, King's College London, St Thomas' Hospital, Room ST0404253 4th Floor Lambeth Wing, St Thomas' Hospital Campus, Westminster Bridge Road, London SE1 7EH, UK.ORCID 0000-0001-5196-9530
St Thomas' Hospital · GBIRCCS Humanitas Research Hospital · ITLewisham and Greenwich NHS Trust · GB

Funding

King's Together Multi and Interdisciplinary Research SchemeOnassis FoundationSpecial Grant & Support Program for Scholars' Association members RZP 001/2019-2020
6 · The paper itself

Abstract

aimsHypertensive patients of African ancestry (Afr-a) have higher incidences of heart failure and worse clinical outcomes than hypertensive patients of European ancestry (Eu-a), yet the underlying mechanisms remain misunderstood. This study investigated right (RV) and left (LV) ventricular remodelling alongside myocardial tissue derangements between Afr-a and Eu-a hypertensives. METHODS AND

results63 Afr-a and 47 Eu-a hypertensives underwent multi-parametric cardiovascular magnetic resonance. Biventricular volumes, mass, function, mass/end-diastolic volume (M/V) ratios, T2 and pre-/post-contrast T1 relaxation times, synthetic extracellular volume, and myocardial fibrosis (MF) were measured. 3D shape modelling was implemented to delineate ventricular geometry. LV and RV mass (indexed to body-surface-area) and M/V ratio were significantly greater in Afr-a than Eu-a hypertensives (67.1 ± 21.7 vs. 58.3 ± 16.7 g/m2, 12.6 ± 3.48 vs. 10.7 ± 2.71 g/m2, 0.79 ± 0.21 vs. 0.70 ± 0.14 g/mL, and 0.16 ± 0.04 vs. 0.13 ± 0.03 g/mL, respectively; P < 0.03). Afr-a patients showed greater basal interventricular septum thickness than Eu-a patients, influencing LV hypertrophy and RV cavity changes. This biventricular remodelling was associated with prolonged T2 relaxation time (47.0 ± 2.2 vs. 45.7 ± 2.2 ms, P = 0.005) and higher prevalence (23% vs. 4%, P = 0.001) and extent of MF [2.3 (0.6-14.3) vs. 1.6 (0.9-2.5) % LV mass, P = 0.008] in Afr-a patients. Multivariable linear regression showed that modifiable cardiovascular risk factors and greater end-diastolic volume, but not ethnicity, were independently associated with greater LV mass.

conclusionAfr-a hypertensives had distinctive biventricular remodelling, including increased RV mass, septal thickening and myocardial tissue abnormalities compared with Eu-a hypertensives. From this study, modifiable cardiovascular risk factors and ventricular geometry, but not ethnicity, were independently associated with greater LV myocardial mass.

Indexed as

Black PeopleHypertensionMagnetic Resonance Imaging, CineVentricular RemodelingWhite PeopleAdultAgedCohort StudiesFemaleHumansHypertrophy, Left VentricularMaleMiddle AgedMyocardiumRisk Assessmentethnicityheart failurehypertensioninflammationmyocardial fibrosisventricular remodelling

Identifiers

PMID38597630
PMCPMC11210986
OpenAlexW4394641956

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.